Article R5121-68-1
When the application for early access authorisation concerns a medicinal product composed, in whole or in part, of genetically modified organisms, the holder of the exploitation rights, or his authori…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 5301–5310 of 59339 articles for “Art. s. 1836 and 1844-6”
When the application for early access authorisation concerns a medicinal product composed, in whole or in part, of genetically modified organisms, the holder of the exploitation rights, or his authori…
…ationale de sécurité du médicament et des produits de santé or the Ministers responsible for health and social security, the applicant has a period of time set by the Haute Autorité de santé which may…
I.-The maximum value of the period referred to in 1° of II of Article L. 5121-12 is set at two years from the date on which the authorisation referred to in this Article is granted. II.-The maximum va…
…121-12-1, the compassionate prescription framework is accompanied by a protocol for therapeutic use and patient follow-up. This protocol specifies in particular 1° The procedures for monitoring patien…
In the event of the formation of sociétés de participations financières de profession libérale de pharmaciens d'officine by merger or takeover, articles R. 5125-24-1 to R. 5125-24-5 are applicable.
…8° of article L. 5125-1-1 A, the dispensing pharmacist may: 1° Implement pharmaceutical monitoring and support measures. They shall prevent iatrogenic medication use. They guarantee the correct use o…
The regional cross-industry joint committees manage the funds received to finance professional transition projects in application of 5° of article L. 6123-5 within two separate financial sections: 1°…
…ce nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail becomes null and void if it appears : 1° That it is not followed by the marketing of the homeopathic veterinary m…
…by the same company or by an associated company or working under licence with the same quantitative and qualitative composition in active ingredients and excipients and the same pharmaceutical form as…
Failing an express decision within the time limit mentioned in Article R. 721-6, the application for approval or amendment of the specification is deemed to have been rejected.
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More